- Home
- CRBG vs FMS Comparison
CRBG vs FMS Comparison
Compare CRBG & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBG
- FMS
- Stock Information
- Founded
- CRBG 1957
- FMS 1996
- Country
- CRBG United States
- FMS Germany
- Employees
- CRBG N/A
- FMS N/A
- Industry
- CRBG Life Insurance
- FMS Misc Health and Biotechnology Services
- Sector
- CRBG Finance
- FMS Health Care
- Exchange
- CRBG Nasdaq
- FMS Nasdaq
- Market Cap
- CRBG 15.6B
- FMS 14.1B
- IPO Year
- CRBG 2022
- FMS 1996
- Fundamental
- Price
- CRBG $29.12
- FMS $23.40
- Analyst Decision
- CRBG Buy
- FMS Sell
- Analyst Count
- CRBG 13
- FMS 2
- Target Price
- CRBG $39.08
- FMS $30.00
- AVG Volume (30 Days)
- CRBG 5.6M
- FMS 486.5K
- Earning Date
- CRBG 11-03-2025
- FMS 11-04-2025
- Dividend Yield
- CRBG 3.30%
- FMS 2.44%
- EPS Growth
- CRBG N/A
- FMS 8.40
- EPS
- CRBG 1.78
- FMS 2.86
- Revenue
- CRBG $18,335,000,000.00
- FMS $23,046,819,198.00
- Revenue This Year
- CRBG $0.38
- FMS $1.75
- Revenue Next Year
- CRBG $5.43
- FMS $3.01
- P/E Ratio
- CRBG $16.35
- FMS $16.08
- Revenue Growth
- CRBG 15.16
- FMS 2.10
- 52 Week Low
- CRBG $23.69
- FMS $21.32
- 52 Week High
- CRBG $36.57
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- CRBG 33.61
- FMS 26.24
- Support Level
- CRBG $29.36
- FMS $23.61
- Resistance Level
- CRBG $30.51
- FMS $24.17
- Average True Range (ATR)
- CRBG 0.96
- FMS 0.40
- MACD
- CRBG -0.18
- FMS -0.29
- Stochastic Oscillator
- CRBG 8.27
- FMS 0.79
About CRBG Corebridge Financial Inc.
Corebridge Financial Inc provides retirement solutions and insurance products in the United States. It offers a broad set of products and services through five segments Individual Retirement, Group Retirement, Life Insurance, Institutional Markets businesses, Corporate and Other. The majority of its revenue derives from the Individual Retirement segment.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.